Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities
Net income	$ 661,508	$ 312,376	$ 128,579
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	577,020	420,692	367,162
Loss on early retirement of debt	0	0	176
Gain on sale of operating properties, including land	(36,372)	(174,384)	(382)
Gain on acquisition of unconsolidated joint venture interests	(474,146)	0	0
Distributions of income from joint ventures	3,015	9,645	8,389
Equity in income of joint ventures	(3,048)	(9,777)	(8,052)
Share-based compensation	12,822	15,397	13,942
Net change in operating accounts and other	3,913	3,518	9,505
Net cash from operating activities	744,712	577,467	519,319
Cash flows from investing activities
Development and capital improvements, including land	(449,431)	(428,714)	(427,247)
Acquisition of operating properties, including joint venture interests, net of cash acquired	(1,066,051)	(629,959)	0
Proceeds from sales of operating properties, including land	70,536	254,717	753
Increase in non-real estate assets	(4,407)	(4,032)	(7,498)
Other	(6,831)	3,597	4,390
Net cash from investing activities	(1,456,184)	(804,391)	(429,602)
Cash flows from financing activities
Proceeds from issuance of common shares	516,758	759,209	0
Distributions to common shareholders and non-controlling interests	(396,822)	(343,039)	(333,360)
Borrowings on unsecured revolving credit facility	758,000	0	358,000
Repayments on unsecured revolving credit facility	(716,000)	0	(402,000)
Repayment of notes payable, including prepayment penalties	(350,000)	0	(100,000)
Proceeds from notes payable	300,000	0	782,823
Payment of deferred financing costs	(10,948)	(1,346)	(1,308)
Other	8,942	6,547	3,162
Net cash from financing activities	109,930	421,371	307,317
Net increase (decrease) in cash, cash equivalents, and restricted cash	(601,542)	194,447	397,034
Cash, cash equivalents, and restricted cash, beginning of year	618,980	424,533	27,499
Cash, cash equivalents, and restricted cash, end of year	17,438	618,980	424,533
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets [Abstract]
Cash and cash equivalents	10,687	613,391	420,441
Restricted cash	6,751	5,589	4,092
Total cash, cash equivalents, and restricted cash	17,438	618,980	424,533
Supplemental information
Cash paid for interest, net of interest capitalized	111,069	97,301	90,297
Cash paid for income taxes	3,216	2,181	2,292
Supplemental schedule of noncash investing and financing activities
Distributions declared but not paid	103,628	88,786	84,147
Value of shares issued under benefit plans, net of cancellations	21,526	18,627	19,560
Accrual associated with construction and capital expenditures	20,151	24,313	29,611
Mortgage debt assumed	514,554	0	0
Other liabilities	39,168	0	0
Right-of-use assets obtained in exchange for the use of new operating lease liabilities	$ 0	$ 0	$ 676